Guidepoint Global Announces Launch of Market Tracker for HAE Therapies (Hereditary Angioedema)

Share Article

Guidepoint Global announced the launch of a new market Tracker for Hereditary Angioedema therapies (HAE) covering the global market for therapies treating the disease. HAE Tracker Clients receive monthly updates on key market evaluation metrics such as treatment volume, HAE market share and therapy switching trends.

HAE Tracker aggregates data from over 100 HAE treatment centers that collectively treat nearly 1,000 patients monthly.

Guidepoint Global, LLC announced the launch of a new Guidepoint Tracker that covers the global market for approved Hereditary Angioedema (HAE) therapies.

Clients receive monthly updates on key HAE market evaluation metrics such as HAE treatment volume, market share, therapy switching trends, delineation of usage (e.g., acute vs. prophylactic, adult vs. pediatric) and qualitative input from allergists and immunologists on various important commercial topics.

In the coming months, Guidepoint’s worldwide HAE Tracker should provide Clients with an objective perspective on FIRAZYR adoption and the impact registered by Shire’s U.S. launch on the competitive landscape, which includes Viropharma’s CINRYZE, Dyax’s Kalbitor and CSL Behring’s Berinert.

Guidepoint Global’s worldwide HAE Tracker aggregates monthly acute and prophylactic treatment data provided by allergists, immunologists and other relevant types of physicians who report from over 100 HAE treatment centers and collectively treat nearly 1,000 diagnosed HAE patients per month, which represents approximately 15% of estimated HAE worldwide market demand.

In addition to HAE Tracker, Guidepoint offers market Trackers for over 25 therapeutic and device categories.

ABOUT GUIDEPOINT TRACKER

Guidepoint Global’s Tracker solutions are longitudinal studies that equip corporations and buy-side institutional investors with monthly volume, market share, pricing and additional commercial insight into medical device and biopharmaceutical utilization reported by representative, same-site samples. Guidepoint Global’s Tracker data and market models are exclusively available to clients via a secure, web-based platform.

See Guidepoint’s website (http://www.guidepointglobal.com) for an overview of Guidepoint Global’s Tracker suite, which includes Trackers within the Aesthetics, Musculoskeletal, Cardiovascular, Ophthalmology, Oral and Therapeutics categories.

To learn more about Guidepoint Tracker please contact:

Zachary Wills
646-395-9344
zwills(at)guidepointglobal(dot)com

ABOUT GUIDEPOINT GLOBAL, LLC
Guidepoint Global is a leading primary research firm that delivers critical business insight through on-demand access to a highly vetted global network of industry experts. Founded in 2003, Guidepoint covers all sectors, geographies and relevant roles. Sector expertise includes Healthcare, Technology, Media, Telecommunications, Energy, Industrials, Consumer Goods & Services, and Financial Services sectors. Clients include some of the world’s leading private equity firms, multinational corporations, consulting firms and asset management firms.

Guidepoint offers primary research services with its network of experts via phone consultations, face-to-face meetings, custom surveys, and proprietary data products. These services, coupled with an industry-leading compliance platform, provide the insight required to make more informed and efficient business decisions.

To learn more about Guidepoint Global’s other products and services, please contact:

Michael Ferrari
212-375-2999
mferrari(at)guidepointglobal(dot)com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Zachary Wills

Brian Cosgrove
Visit website